Terminated PHASE4 INTERVENTIONAL 2-arm NCT01887483

Vetal Laban Intervention Trial Assessing Bowel Symptoms (KF_2013)

A Double-Blind Placebo-Controlled Randomized Clinical Trial Assessing the Effect of 2 Month Consumption of Vetal Laban Including L. Acidophilus on Functional Gastrointestinal Symptoms Among Subjects Fulfilling Rome III Criteria for IBS

Sponsor: Almarai

Conditions Irritable Bowel Syndrome

Interventions Placebo Vetal Laban active

Updated 5 times since 2017 Last updated: Dec 21, 2015 Started: Mar 31, 2014 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow recruitment, high drop-out

Other Irritable Bowel Syndrome trials with similar outcome

Browse all Irritable Bowel Syndrome trials

This PHASE4 trial investigates Irritable Bowel Syndrome and is currently terminated or withdrawn. Almarai leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Almarai
Clinart International
Danisco

Data source: Danisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Riyadh, Saudi Arabia